High parathyroid hormone, but not low vitamin D concentrations, expose elderly inpatients to hypertension

Aim:  Serum parathyroid hormone (PTH) and 25‐hydroxyvitamin D (25OHD) concentrations might contribute to blood pressure (BP) levels. Mixed results in previous literature could be due to the failure to consider both these hormones concurrently, despite their long‐known relationship. Our objective was to examine the association of serum intact PTH and 25OHD concentrations with BP levels amongst older inpatients, while accounting for each other.

[1]  C. Annweiler,et al.  [Vitamin D in the elderly: 5 points to remember]. , 2011, Geriatrie et psychologie neuropsychiatrie du vieillissement.

[2]  H. Schiffl,et al.  Hypertension Secondary to PHPT: Cause or Coincidence? , 2011, International journal of endocrinology.

[3]  S. Adámek,et al.  Improvement of Hypertension after Parathyroidectomy of Patients Suffering from Primary Hyperparathyroidism , 2011, International journal of endocrinology.

[4]  T. Trikalinos,et al.  Systematic Review: Vitamin D and Cardiometabolic Outcomes , 2010, Annals of Internal Medicine.

[5]  V. Tangpricha,et al.  Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. , 2009, Surgery.

[6]  A. Ayav,et al.  Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. , 2009, Surgery.

[7]  A. Struthers,et al.  Effect of vitamin D on blood pressure: a systematic review and meta-analysis , 2009, Journal of hypertension.

[8]  G. Curhan,et al.  Parathyroid hormone and the risk of incident hypertension , 2008, Journal of Hypertension.

[9]  M. Holick,et al.  Vitamin D deficiency: a worldwide problem with health consequences. , 2008, The American journal of clinical nutrition.

[10]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[11]  M. Visser,et al.  Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population‐based study in older men and women , 2007, Journal of internal medicine.

[12]  N. Vaziri,et al.  Low albumin levels increase endothelial NO production and decrease vascular NO sensitivity. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  J. Gujral,et al.  Hyperthyroidism: A Secondary Cause of Isolated Systolic Hypertension , 2006, Journal of clinical hypertension.

[14]  B. Krämer,et al.  Calcium Inhibits Renin Gene Expression by Transcriptional and Posttranscriptional Mechanisms , 2005, Hypertension.

[15]  J. Svartberg,et al.  Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men , 2005, Journal of hypertension.

[16]  H. Cross,et al.  Vitamin D and calcium deficits predispose for multiple chronic diseases , 2005, European journal of clinical investigation.

[17]  E. Roccella,et al.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Circulation.

[18]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[19]  J. Rastad,et al.  Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. , 2001, Surgery.

[20]  K. Rahn,et al.  Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. , 2000, Cardiovascular research.

[21]  S. Oparil,et al.  Essential Hypertension : Part I : Definition and Etiology , 1999 .

[22]  K. Bønaa,et al.  Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Tromsø study. , 1999, European journal of endocrinology.

[23]  J. Abrahamsen,et al.  Effects of PTH(1-34) on blood pressure, renal function, and hormones in essential hypertension: the altered pattern of reactivity may counteract raised blood pressure. , 1997, American journal of hypertension.

[24]  F P Cappuccio,et al.  Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. , 1995, American journal of epidemiology.

[25]  P. Metcalf,et al.  Serum 25-hydroxycholecalciferol concentration in newly detected hypertension. , 1995, American journal of hypertension.

[26]  S. Linas,et al.  Parathyroid hormone/adenylate cyclase coupling in vascular smooth muscle cells. , 1994, Hypertension.

[27]  J. Rastad,et al.  Relationship between abnormal regulation of cytoplasmic calcium and elevated blood pressure in patients with primary hyperparathyroidism. , 1994, Journal of human hypertension.

[28]  P. Vallance,et al.  Nitric oxide and cardiovascular control , 1993, Experimental physiology.

[29]  S. Mandel,et al.  Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. , 1992, The Journal of clinical endocrinology and metabolism.

[30]  D. Neuser,et al.  Development of Hypertension in WKY Rats After Transplantation of Parathyroid Glands from SHR/SP , 1990, Journal of cardiovascular pharmacology.

[31]  E. Ritz,et al.  Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cellsIn vitro , 1987, Calcified Tissue International.

[32]  H. Hulter,et al.  Chronic continuous PTH infusion results in hypertension in normal subjects. , 1986, Journal of clinical hypertension.

[33]  R. Rubin,et al.  Enhanced Parathyroid Function in Essential Hypertension A Homeostatic Response to a Urinary Calcium Leak , 1980, Hypertension.

[34]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[35]  T. Ogihara,et al.  Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. , 1998, Journal of cardiovascular pharmacology.

[36]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.

[37]  S. Gonnelli,et al.  Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. , 1995, Mineral and electrolyte metabolism.

[38]  R. Lewanczuk,et al.  Parathyroid hypertensive factor. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.